Rapid Bladder Cancer Test
Delivery Restriction
This product cannot be shipped to your selected delivery address/country. Purchase has been disabled.
Product Information
Product Description
UBC® is an immunoassay for both primary diagnosis and monitoring of bladder cancer. The test specifically measures soluble fragments of cytokeratin 8 and 18 in urine samples. . Elevated amounts of cytokeratin protein fragments are present in the urine of many individuals with bladder cancer, even at early stages of the disease.
UBC® is available in Rapid, ELISA and IRMA format.
UBC® Rapid is a powerful Doctors-office test (Point-of-Care), for both primary diagnosis and monitoring of bladder cancer. The test specifically measures soluble fragments of cytokeratin 8 and 18 in urine samples. It can easily be performed by a nurse or a technician with minimal training and the results are obtained within 10 minutes. Elevated amounts of cytokeratin protein fragments are present in the urine of many individuals with bladder cancer, even at early stages of the disease.
UBC® Rapid shall be used for quantitative determination in combination with the POC-reader, concile® Ω100.
– The only quantitative POC test platform for urine based detection of bladder cancer.
– Easy and rapid to perform – result within 10 minutes
– Works in haematuria
Additional Information
- • Seller Company: Idl Biotech
- • Stock Status: In Stock
- • VAT Rate: %20
- • Delivery Status: Select address for delivery eligibility.
